GlassScriptPhysician profile
Alejandro Gomez-Viso
NPI 1245763820
$5,091.77
in general payments reported to CMS, 2019-2025
12 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.82 · 2023: $156 · 2024: $4,345 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,653 · Food and Beverage: $1,216 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,653.31 |
| Food and Beverage | $1,216.02 |
| Education | $182.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,563.92 | 2021-2024 | Interstim |
| Axonics, INC. | $1,945.17 | 2024 | Axonics, Bulkamid |
| Escala Medical INC. | $208.40 | 2025 | |
| Abbvie INC. | $107.32 | 2021-2025 | |
| Boston Scientific Corporation | $50.32 | 2025 | Axonics |
| Millicent US INC | $46.75 | 2025 | Femlyv, Intrarosa |
| Daiichi Sankyo INC. | $46.09 | 2025 | Injectafer |
| Mayne Pharma Commercial LLC | $42.54 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.58 | 2025 | |
| Valencia Technologies Corporation | $19.49 | 2025 | Ecoin Device Kit |
| Sumitomo Pharma America, INC. | $19.38 | 2025 | Myfembree |
| Abc Home Medical Supply, INC. | $17.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Gomez-Viso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.